{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:07:10Z","timestamp":1791223630233,"version":"4.1.0"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,9,1]]},"DOI":"10.1097\/qai.0b013e318074eb73","type":"journal-article","created":{"date-parts":[[2007,5,18]],"date-time":"2007-05-18T17:37:15Z","timestamp":1179509835000},"page":"12-18","source":"Crossref","is-referenced-by-count":42,"title":["Prevalence of HIV-1 Drug Resistance in Treated Patients"],"prefix":"10.1097","volume":"46","author":[{"given":"Dominique","family":"Costagliola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Descamps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lambert","family":"Assoumou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Morand-Joubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Genevi\u00e8ve","family":"Marcelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Brodard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance","family":"Delaugerre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Mackiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annick","family":"Ruffault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Izopet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Plantier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Tamalet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Yerly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souhaha","family":"Saidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Brun-Vezinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Masquelier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210131","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"R2-2-20210131","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jama.296.7.827","article-title":"Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel.","volume":"296","author":"Hammer","year":"2006","journal-title":"JAMA"},{"key":"R3-2-20210131","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1086\/375597","article-title":"Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel.","volume":"37","author":"Hirsch","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R4-2-20210131","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1086\/344358","article-title":"Mechanisms of early virologic failure in antiretroviral-naive patients starting protease inhibitor-containing regimens: the APROVIR Study.","volume":"186","author":"Masquelier","year":"2002","journal-title":"J Infect Dis"},{"key":"R5-2-20210131","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1086\/432916","article-title":"Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management.","volume":"192","author":"Wensing","year":"2005","journal-title":"J Infect Dis"},{"key":"R6-2-20210131","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/01.qai.0000219290.49152.6a","article-title":"Tracking the prevalence of transmitted antiretroviral drug-resistant HIV-1: a decade of experience.","volume":"41","author":"Shet","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R7-2-20210131","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/01.qai.0000186361.42834.61","article-title":"Prevalence of transmitted HIV-1 drug resistance and the role of resistance algorithms: data from seroconverters in the CASCADE collaboration from 1987 to 2003.","volume":"40","author":"Masquelier","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R8-2-20210131","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/nm0901-1016","article-title":"Predicting the unpredictable: transmission of drug-resistant HIV.","volume":"7","author":"Blower","year":"2001","journal-title":"Nat Med"},{"key":"R9-2-20210131","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1097\/01.aids.0000131310.52526.c7","article-title":"The prevalence of antiretroviral drug resistance in the United States.","volume":"18","author":"Richman","year":"2004","journal-title":"AIDS"},{"key":"R10-2-20210131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/088922204322749440","article-title":"HIV type 1 genotypic resistance in a clinical database correlates with antiretroviral utilization.","volume":"20","author":"Kagan","year":"2004","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R11-2-20210131","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1097\/00002030-200311070-00014","article-title":"Resistance of HIV-1 to multiple antiretroviral drugs in France: a 6-year survey (1997-2002) based on an analysis of over 7000 genotypes.","volume":"17","author":"Tamalet","year":"2003","journal-title":"AIDS"},{"key":"R12-2-20210131","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/jac\/dkh102","article-title":"Surveillance of HIV antiretroviral drug resistance in treated individuals in England: 1998-2000.","volume":"53","author":"Scott","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"R13-2-20210131","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/jmv.20522","article-title":"Repeated HIV-1 resistance genotyping external quality assessments improve virology laboratory performance.","volume":"78","author":"Descamps","year":"2006","journal-title":"J Med Virol"},{"key":"R14-2-20210131","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/(SICI)1097-0258(19970228)16:4<397::AID-SIM391>3.0.CO;2-T","article-title":"Estimating means and percentages in a complex sampling survey: application to a French national survey on sexual behaviour (ACSF). Analyse des Comportements Sexuels en France.","volume":"16","author":"Warszawski","year":"1997","journal-title":"Stat Med"},{"key":"R16-2-20210131","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/jmv.20380","article-title":"Prevalence of complete resistance to at least two classes of antiretroviral drugs in treated HIV-1-infected patients: a French nationwide study.","volume":"76","author":"Masquelier","year":"2005","journal-title":"J Med Virol"},{"key":"R17-2-20210131","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1086\/428852","article-title":"HIV-1 drug resistance: degree of underestimation by a cross-sectional versus a longitudinal testing approach.","volume":"191","author":"Harrigan","year":"2005","journal-title":"J Infect Dis"},{"key":"R18-2-20210131","doi-asserted-by":"crossref","first-page":"7094","DOI":"10.1073\/pnas.0602033103","article-title":"Persistence of nevirapine-resistant HIV-1 in women after single-dose nevirapine therapy for prevention of maternal-to-fetal HIV-1 transmission.","volume":"103","author":"Palmer","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"R19-2-20210131","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1177\/135965350601100506","article-title":"Declining prevalence of HIV-infected individuals at risk of transmitting drug-resistant HIV in Denmark during 1997-2004.","volume":"11","author":"Lohse","year":"2006","journal-title":"Antivir Ther"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/QAI.0b013e318074eb73","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:41:06Z","timestamp":1786034466000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00126334-200709010-00002"}},"subtitle":["A French Nationwide Study"],"short-title":[],"issued":{"date-parts":[[2007,9,1]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e318074eb73","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9,1]]}}}